Cargando…
Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives
SIMPLE SUMMARY: Management of gastrointestinal (GI) cancers t is a worldwide challenge and some new tools are needed to guide it. Circulating tumor DNA (ctDNA) is a fraction of tumor DNA that can be detected by a liquid biopsy through a simple blood sample. In this work, we tried to summarize in a c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507552/ https://www.ncbi.nlm.nih.gov/pubmed/34638228 http://dx.doi.org/10.3390/cancers13194743 |
_version_ | 1784581883091222528 |
---|---|
author | Moati, Emilie Taly, Valerie Garinet, Simon Didelot, Audrey Taieb, Julien Laurent-Puig, Pierre Zaanan, Aziz |
author_facet | Moati, Emilie Taly, Valerie Garinet, Simon Didelot, Audrey Taieb, Julien Laurent-Puig, Pierre Zaanan, Aziz |
author_sort | Moati, Emilie |
collection | PubMed |
description | SIMPLE SUMMARY: Management of gastrointestinal (GI) cancers t is a worldwide challenge and some new tools are needed to guide it. Circulating tumor DNA (ctDNA) is a fraction of tumor DNA that can be detected by a liquid biopsy through a simple blood sample. In this work, we tried to summarize in a clinical review to what extend the analysis of ctDNA can improve therapeutic support in digestive oncology and how this circulating biomarker appears as a very promising improvement in addition to classic diagnostic, prognostic and theranostic methods. Although the level of evaluation of this tool is still different between the different GI cancers locations, it is in dynamic evolution in all of them. ABSTRACT: Gastrointestinal (GI) cancers are major health burdens worldwide and biomarkers are needed to improve the management of these diseases along their evolution. Circulating tumor DNA (ctDNA) is a promising non-invasive blood and other bodily-fluid-based biomarker in cancer management that can help clinicians in various cases for the detection, diagnosis, prognosis, monitoring and personalization of treatment in digestive oncology. In addition to the well-studied prognostic role of ctDNA, the main real-world applications appear to be the assessment of minimal residual disease to further guide adjuvant therapy and predict relapse, but also the monitoring of clonal evolution to tailor treatments in metastatic setting. Other challenges such as predicting response to treatment including immune checkpoint inhibitors could also be among the potential applications of ctDNA. Although the level of advancement of ctDNA development in the different tumor localizations is still inhomogeneous, it might be now reliable enough to be soon used in clinical routine for colorectal cancers and shows promising results in other GI cancers. |
format | Online Article Text |
id | pubmed-8507552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85075522021-10-13 Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives Moati, Emilie Taly, Valerie Garinet, Simon Didelot, Audrey Taieb, Julien Laurent-Puig, Pierre Zaanan, Aziz Cancers (Basel) Review SIMPLE SUMMARY: Management of gastrointestinal (GI) cancers t is a worldwide challenge and some new tools are needed to guide it. Circulating tumor DNA (ctDNA) is a fraction of tumor DNA that can be detected by a liquid biopsy through a simple blood sample. In this work, we tried to summarize in a clinical review to what extend the analysis of ctDNA can improve therapeutic support in digestive oncology and how this circulating biomarker appears as a very promising improvement in addition to classic diagnostic, prognostic and theranostic methods. Although the level of evaluation of this tool is still different between the different GI cancers locations, it is in dynamic evolution in all of them. ABSTRACT: Gastrointestinal (GI) cancers are major health burdens worldwide and biomarkers are needed to improve the management of these diseases along their evolution. Circulating tumor DNA (ctDNA) is a promising non-invasive blood and other bodily-fluid-based biomarker in cancer management that can help clinicians in various cases for the detection, diagnosis, prognosis, monitoring and personalization of treatment in digestive oncology. In addition to the well-studied prognostic role of ctDNA, the main real-world applications appear to be the assessment of minimal residual disease to further guide adjuvant therapy and predict relapse, but also the monitoring of clonal evolution to tailor treatments in metastatic setting. Other challenges such as predicting response to treatment including immune checkpoint inhibitors could also be among the potential applications of ctDNA. Although the level of advancement of ctDNA development in the different tumor localizations is still inhomogeneous, it might be now reliable enough to be soon used in clinical routine for colorectal cancers and shows promising results in other GI cancers. MDPI 2021-09-22 /pmc/articles/PMC8507552/ /pubmed/34638228 http://dx.doi.org/10.3390/cancers13194743 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Moati, Emilie Taly, Valerie Garinet, Simon Didelot, Audrey Taieb, Julien Laurent-Puig, Pierre Zaanan, Aziz Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives |
title | Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives |
title_full | Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives |
title_fullStr | Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives |
title_full_unstemmed | Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives |
title_short | Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives |
title_sort | role of circulating tumor dna in gastrointestinal cancers: current knowledge and perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507552/ https://www.ncbi.nlm.nih.gov/pubmed/34638228 http://dx.doi.org/10.3390/cancers13194743 |
work_keys_str_mv | AT moatiemilie roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives AT talyvalerie roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives AT garinetsimon roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives AT didelotaudrey roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives AT taiebjulien roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives AT laurentpuigpierre roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives AT zaananaziz roleofcirculatingtumordnaingastrointestinalcancerscurrentknowledgeandperspectives |